C Heilmann1, W Ziebuhr2, K Becker3. 1. Institute of Medical Microbiology, University Hospital Münster, Münster, Germany. 2. Institute for Molecular Infection Biology, University of Würzburg, Würzburg, Germany. 3. Institute of Medical Microbiology, University Hospital Münster, Münster, Germany. Electronic address: kbecker@uni-muenster.de.
Abstract
BACKGROUND: Progress in contemporary medicine is associated with an increasing number of immunocompromised individuals. In this vulnerable group, the underlying disease together with long-term hospitalization and the use of medical devices facilitate infections by opportunistic pathogens, of which coagulase-negative staphylococci (CoNS) represent a prime example. OBJECTIVES: The diversity of CoNS with species- and strain-specific differences concerning virulence and clinical impact is highlighted. A focus is on the ability of CoNS to generate biofilms on biotic and abiotic surfaces, which enables skin and mucosa colonization as well as establishment of CoNS on indwelling foreign bodies. SOURCES: Literature about the virulence of CoNS listed in PubMed was reviewed. CONTENT: Most catheter-related and prosthetic joint infections as well as most other device-related infections are caused by CoNS, specifically by Staphylococcus epidermidis and Staphylococcus haemolyticus. A common theme of CoNS infections is a high antibiotic resistance rate, which often limits treatment options and contributes to the significant health and economic burden imposed by CoNS. IMPLICATIONS: Breaching the skin barrier along with the insertion of medical devices offers CoNS opportunities to gain access to host tissues and to sustain there by forming biofilms on foreign body surfaces. Biofilms represent the perfect niche to protect CoNS from both the host immune response and the action of antibiotics. Their particular lifestyle, combined with conditions that facilitate host colonization and infection, has led to the growing impact of CoNS as pathogens. Moreover, CoNS may serve as hidden reservoirs for antibiotic resistance and virulence traits.
BACKGROUND: Progress in contemporary medicine is associated with an increasing number of immunocompromised individuals. In this vulnerable group, the underlying disease together with long-term hospitalization and the use of medical devices facilitate infections by opportunistic pathogens, of which coagulase-negative staphylococci (CoNS) represent a prime example. OBJECTIVES: The diversity of CoNS with species- and strain-specific differences concerning virulence and clinical impact is highlighted. A focus is on the ability of CoNS to generate biofilms on biotic and abiotic surfaces, which enables skin and mucosa colonization as well as establishment of CoNS on indwelling foreign bodies. SOURCES: Literature about the virulence of CoNS listed in PubMed was reviewed. CONTENT: Most catheter-related and prosthetic joint infections as well as most other device-related infections are caused by CoNS, specifically by Staphylococcus epidermidis and Staphylococcus haemolyticus. A common theme of CoNS infections is a high antibiotic resistance rate, which often limits treatment options and contributes to the significant health and economic burden imposed by CoNS. IMPLICATIONS: Breaching the skin barrier along with the insertion of medical devices offers CoNS opportunities to gain access to host tissues and to sustain there by forming biofilms on foreign body surfaces. Biofilms represent the perfect niche to protect CoNS from both the host immune response and the action of antibiotics. Their particular lifestyle, combined with conditions that facilitate host colonization and infection, has led to the growing impact of CoNS as pathogens. Moreover, CoNS may serve as hidden reservoirs for antibiotic resistance and virulence traits.
Authors: Niccolò Buetti; Mohamed Abbas; Didier Pittet; Marlieke E A de Kraker; Daniel Teixeira; Marie-Noëlle Chraiti; Valérie Sauvan; Julien Sauser; Stephan Harbarth; Walter Zingg Journal: JAMA Intern Med Date: 2021-11-01 Impact factor: 44.409
Authors: Xin Du; Jesper Larsen; Min Li; Axel Walter; Christoph Slavetinsky; Anna Both; Patricia M Sanchez Carballo; Marc Stegger; Esther Lehmann; Yao Liu; Junlan Liu; Jessica Slavetinsky; Katarzyna A Duda; Bernhard Krismer; Simon Heilbronner; Christopher Weidenmaier; Christoph Mayer; Holger Rohde; Volker Winstel; Andreas Peschel Journal: Nat Microbiol Date: 2021-05-24 Impact factor: 17.745
Authors: Gabriella Marincola; Olivia Liong; Christoph Schoen; Alaa Abouelfetouh; Aisha Hamdy; Freya D R Wencker; Tessa Marciniak; Karsten Becker; Robin Köck; Wilma Ziebuhr Journal: Front Public Health Date: 2021-06-17
Authors: Cihan Papan; Matthias Schröder; Mathias Hoffmann; Heike Knoll; Katharina Last; Frederic Albrecht; Jürgen Geisel; Tobias Fink; Barbara C Gärtner; Alexander Mellmann; Thomas Volk; Fabian K Berger; Sören L Becker Journal: Antimicrob Resist Infect Control Date: 2021-06-30 Impact factor: 4.887